![Meenu Chhabra Karson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Meenu Chhabra Karson
Directeur/Membre du Conseil chez
MACROGENICS, INC.
Fortune : 61 360 $ au 31/05/2026
Profil
Meenu Chhabra Karson is currently Chief Executive Officer at Evercrisp Biosciences, Inc. since 2024.
Also holds positions as Independent Director at MacroGenics, Inc. since 2023, Director at Vasomune Therapeutics, Inc. since 2020, Director at Fore Biotherapeutics, Inc., and Member at Biotechnology Innovation Organization.
Former roles include President, Chief Executive Officer & Director at Allozyne, Inc. from 2007 to 2014; President, Chief Executive Officer & Director at Proteostasis Therapeutics, Inc. from 2014 to 2020; Executive Chairman at Samsara Therapeutics, Inc.; Chairman at Apexigen America, Inc. from 2022 to 2023; Independent Director at Vallon Pharmaceuticals, Inc. from 2022 to 2023; Principal at Bristol Myers Squibb Co., Warner-Lambert Co., Parke-Davis & Co. Ltd., Fresenius Kabi AG, and NeurAxon, Inc.; Chief Business Officer at BioXell SpA from 2003 to 2006; Vice President-Business Development & Licensing at Novartis AG in 2007.
Education includes undergraduate studies at the University of Toronto and an MBA from The Schulich School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MACROGENICS, INC. 0,02 % | 19/05/2026 | 14 750 ( 0,02 % ) | 61 360 $ | 31/05/2026 |
Postes actifs de Meenu Chhabra Karson
| Sociétés | Poste | Début |
|---|---|---|
| MACROGENICS, INC. | Directeur/Membre du Conseil | 03/01/2023 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | - |
Evercrisp Biosciences, Inc.
 Evercrisp Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as ab biotechnology company that discovery and development of protein-based genome editors as therapeutics for multiple disease areas | Directeur Général | 01/09/2024 |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Directeur/Membre du Conseil | - |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops medications for treatment of diseases associated with vascular dysfunction | Directeur/Membre du Conseil | 24/03/2020 |
Anciens postes connus de Meenu Chhabra Karson
| Sociétés | Poste | Fin |
|---|---|---|
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Président | 01/08/2023 |
| GRI BIOPAR | Directeur/Membre du Conseil | 21/04/2023 |
| PROTEOSTASIS THERAPEUTICS, INC. | Directeur Général | 01/12/2020 |
Allozyne, Inc.
 Allozyne, Inc. Medical SpecialtiesHealth Technology Develops and manufactures pharmaceutical products | Directeur Général | 01/05/2014 |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Meenu Chhabra Karson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Health Technology |
BioXell SpA
 BioXell SpA BiotechnologyHealth Technology Manufactures drugs for inflammatory diseases | Health Technology |
Allozyne, Inc.
Allozyne, Inc. Medical SpecialtiesHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for oncology & autoimmune diseases | Health Technology |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Health Technology |
The Schulich School of Business
 The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops medications for treatment of diseases associated with vascular dysfunction | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that specializes in cancer therapies | Health Technology |
Samsara Therapeutics, Inc.
 Samsara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes first-in-class therapeutics for the treatment of unmet medical needs and age-related diseases | Health Technology |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Evercrisp Biosciences, Inc.
Evercrisp Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as ab biotechnology company that discovery and development of protein-based genome editors as therapeutics for multiple disease areas | Commercial Services |
Choisissez Zonebourse 
